These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9504471)

  • 81. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis.
    Ge Y; Grossman RI; Babb JS; He J; Mannon LJ
    AJNR Am J Neuroradiol; 2003; 24(10):1935-40. PubMed ID: 14625213
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Enhanced and unenhanced MR with magnetization transfer in multiple sclerosis.
    Bozzao A; Bastianello S; Ferone E; Giugni E; Paolillo A; Bozzao L
    AJNR Am J Neuroradiol; 1996; 17(10):1837-42. PubMed ID: 8933866
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Quantification of magnetization transfer rate and native T1 relaxation time of the brain: correlation with magnetization transfer ratio measurements in patients with multiple sclerosis.
    Karampekios S; Papanikolaou N; Papadaki E; Maris T; Uffman K; Spilioti M; Plaitakis A; Gourtsoyiannis N
    Neuroradiology; 2005 Mar; 47(3):189-96. PubMed ID: 15711987
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions.
    Nayak NB; Salah R; Huang JC; Hathout GM
    Acta Neurol Scand; 2014 Mar; 129(3):198-203. PubMed ID: 23980614
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions.
    van Waesberghe JH; Castelijns JA; Scheltens P; Truyen L; Lycklana A Nijeholt GJ; Hoogenraad FG; Polman CH; Valk J; Barkhof F
    Magn Reson Imaging; 1997; 15(2):155-62. PubMed ID: 9106143
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Automatic segmentation of gadolinium-enhanced multiple sclerosis lesions.
    Bedell BJ; Narayana PA
    Magn Reson Med; 1998 Jun; 39(6):935-40. PubMed ID: 9621917
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
    De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
    Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of two MR sequences for the detection of multiple sclerosis lesions in the spinal cord.
    Lycklama à Nijeholt GJ; Barkhof F; Castelijns JA; van Waesberghe JH; Valk J; Jongen PJ; Hommes OR
    AJNR Am J Neuroradiol; 1996 Sep; 17(8):1533-8. PubMed ID: 8883653
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Intraobserver and interobserver variability in schemes for estimating volume of brain lesions on MR images in multiple sclerosis.
    Filippi M; Horsfield MA; Rovaris M; Yousry T; Rocca MA; Baratti C; Bressi S; Comi G
    AJNR Am J Neuroradiol; 1998 Feb; 19(2):239-44. PubMed ID: 9504472
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study.
    Grimaud J; Barker GJ; Wang L; Lai M; MacManus DG; Webb SL; Thompson AJ; McDonald WI; Tofts PS; Miller DH
    J Neurol; 1999 Oct; 246(10):961-7. PubMed ID: 10552247
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Multiparametric Characterization and Spatial Distribution of Different MS Lesion Phenotypes.
    Tazza F; Boffa G; Schiavi S; Lapucci C; Piredda GF; Cipriano E; Zacà D; Roccatagliata L; Hilbert T; Kober T; Inglese M; Costagli M
    AJNR Am J Neuroradiol; 2024 Aug; 45(8):1166-1174. PubMed ID: 38816021
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity.
    Trop I; Bourgouin PM; Lapierre Y; Duquette P; Wolfson CM; Duong HD; Trudel GC
    AJNR Am J Neuroradiol; 1998; 19(6):1025-33. PubMed ID: 9672006
    [TBL] [Abstract][Full Text] [Related]  

  • 94. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability.
    Lycklama à Nijeholt GJ; Barkhof F; Scheltens P; Castelijns JA; Adèr H; van Waesberghe JH; Polman C; Jongen SJ; Valk J
    AJNR Am J Neuroradiol; 1997; 18(6):1041-8. PubMed ID: 9194431
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Infratentorial lesion volume correlates with sensory functional system in multiple sclerosis patients: a 3.0-Tesla MRI study.
    Quattrocchi CC; Cherubini A; Luccichenti G; Grasso MG; Nocentini U; Beomonte Zobel B; Sabatini U
    Radiol Med; 2010 Feb; 115(1):115-24. PubMed ID: 20017006
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics.
    Kilsdonk ID; Lopez-Soriano A; Kuijer JP; de Graaf WL; Castelijns JA; Polman CH; Luijten PR; Geurts JJ; Barkhof F; Wattjes MP
    J Neurol; 2014 Jul; 261(7):1356-64. PubMed ID: 24777693
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Two-dimensional accelerated MP-RAGE imaging with flexible linear reordering.
    Brenner D; Stirnberg R; Pracht ED; Stöcker T
    MAGMA; 2014 Oct; 27(5):455-62. PubMed ID: 24510154
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Computerized method of lesion volume quantitation in multiple sclerosis: error of serial studies.
    Simon JH; Scherzinger A; Raff U; Li X
    AJNR Am J Neuroradiol; 1997 Mar; 18(3):580-2. PubMed ID: 9090427
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A genome-wide association study of brain lesion distribution in multiple sclerosis.
    Gourraud PA; Sdika M; Khankhanian P; Henry RG; Beheshtian A; Matthews PM; Hauser SL; Oksenberg JR; Pelletier D; Baranzini SE
    Brain; 2013 Apr; 136(Pt 4):1012-24. PubMed ID: 23412934
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evaluation of the clinical utility of maximum intensity projections of 3D contrast-enhanced, T1-weighted imaging for the detection of brain metastases.
    Hainc N; Federau C; Tyndall A; Mittermeier A; Bink A; Stippich C; Schubert T
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1277. PubMed ID: 32770649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.